Literature DB >> 7856428

Interleukin-1, interleukin-6 and tumor necrosis factor at delivery in preeclamptic disorders.

S L Opsjøn1, R Austgulen, A Waage.   

Abstract

BACKGROUND: To examine if preeclamptic disorders lead to altered concentrations of tumor necrosis factor, interleukin-1 and interleukin-6 at delivery compared to normal pregnancy.
METHODS: Amniotic fluid, placenta, maternal and cord serum were collected at delivery by cesarean section or spontaneous labor. Samples were retrieved from 53 women with normal pregnancy, 54 with preeclamptic disorders and 15 who delivered a small for gestational neonate of unknown cause. Cytokines were measured by bioassays. Statistics were performed with nonparametric tests.
RESULTS: Interleukin-1 in amniotic fluid tended to be lower with preeclamptic disorders than in normal pregnancy irrespective of labor. There was an increase in amniotic fluid tumor necrosis factor, interleukin-1 and interleukin-6 with onset of labor in preeclamptic disorders just as in normal pregnancy. There was a similar increase in interleukin-6 in cord and maternal serum in the same groups, even if concentration of interleukin-6 in cord serum in labor of preeclamptic disorders was lower than in normal pregnancy.
CONCLUSIONS: No major differences were seen in concentrations of interleukin-1, interleukin-6 and tumor necrosis factor in amniotic fluid, placenta, maternal or cord serum at delivery with preeclamptic disorders compared to normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7856428     DOI: 10.3109/00016349509009937

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

Review 1.  Toll-like receptors in pregnancy disorders and placental dysfunction.

Authors:  Joan K Riley; D Michael Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

2.  Umbilical cord serum cytokine levels and risks of small-for-gestational-age and preterm birth.

Authors:  Gila I Neta; Ondine S von Ehrenstein; Lynn R Goldman; Kirsten Lum; Rajeshwari Sundaram; William Andrews; Jun Zhang
Journal:  Am J Epidemiol       Date:  2010-03-26       Impact factor: 4.897

3.  Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Authors:  Alaa Amash; Gershon Holcberg; Olga Sapir; Mahmoud Huleihel
Journal:  J Interferon Cytokine Res       Date:  2012-08-21       Impact factor: 2.607

4.  Circulating and placental growth-differentiation factor 15 in preeclampsia and in pregnancy complicated by diabetes mellitus.

Authors:  Meryam Sugulle; Ralf Dechend; Florian Herse; M Susanne Weedon-Fekjaer; Guro M Johnsen; K Bridget Brosnihan; Lauren Anton; Friedrich C Luft; Kai C Wollert; Tibor Kempf; Anne Cathrine Staff
Journal:  Hypertension       Date:  2009-05-26       Impact factor: 10.190

5.  Preeclampsia-related inflammatory cytokines regulate interleukin-6 expression in human decidual cells.

Authors:  Charles J Lockwood; Chih-Feng Yen; Murat Basar; Umit A Kayisli; Maritza Martel; Irina Buhimschi; Catalin Buhimschi; S Joseph Huang; Graciela Krikun; Frederick Schatz
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

Review 6.  Role of placentally produced inflammatory and regulatory cytokines in pregnancy and the etiology of preeclampsia.

Authors:  Corinne Rusterholz; Sinuhe Hahn; Wolfgang Holzgreve
Journal:  Semin Immunopathol       Date:  2007-06       Impact factor: 11.759

7.  Adiponectin levels are reduced while markers of systemic inflammation and aortic remodelling are increased in intrauterine growth restricted mother-child couple.

Authors:  Silvia Visentin; Annunziata Lapolla; Ambrogio Pietro Londero; Chiara Cosma; Mariagrazia Dalfrà; Martina Camerin; Diego Faggian; Mario Plebani; Erich Cosmi
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

8.  Combined Effects of Methyldopa and Flavonoids on the Expression of Selected Factors Related to Inflammatory Processes and Vascular Diseases in Human Placenta Cells-An In Vitro Study.

Authors:  Anna Bogacz; Przemysław Ł Mikołajczak; Marlena Wolek; Aleksandra Górska; Michał Szulc; Marcin Ożarowski; Radosław Kujawski; Bogusław Czerny; Hubert Wolski; Tomasz M Karpiński; Agnieszka Seremak-Mrozikiewicz
Journal:  Molecules       Date:  2021-02-26       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.